nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—TEK—artery—intracranial aneurysm	0.0136	0.0343	CbGeAlD
Vandetanib—SRC—artery—intracranial aneurysm	0.0121	0.0305	CbGeAlD
Vandetanib—KDR—artery—intracranial aneurysm	0.0111	0.028	CbGeAlD
Vandetanib—TYRO3—brainstem—intracranial aneurysm	0.00932	0.0235	CbGeAlD
Vandetanib—STK35—brainstem—intracranial aneurysm	0.00777	0.0196	CbGeAlD
Vandetanib—EPHA5—medulla oblongata—intracranial aneurysm	0.0065	0.0164	CbGeAlD
Vandetanib—EPHA8—cerebellum—intracranial aneurysm	0.00594	0.015	CbGeAlD
Vandetanib—EPHA5—midbrain—intracranial aneurysm	0.00594	0.015	CbGeAlD
Vandetanib—FYN—brainstem—intracranial aneurysm	0.00593	0.0149	CbGeAlD
Vandetanib—LTK—brain—intracranial aneurysm	0.00503	0.0127	CbGeAlD
Vandetanib—RIPK2—medulla oblongata—intracranial aneurysm	0.00499	0.0126	CbGeAlD
Vandetanib—STK35—midbrain—intracranial aneurysm	0.00495	0.0125	CbGeAlD
Vandetanib—IRAK4—medulla oblongata—intracranial aneurysm	0.00488	0.0123	CbGeAlD
Vandetanib—EPHA8—brain—intracranial aneurysm	0.00483	0.0122	CbGeAlD
Vandetanib—MAP2K5—brainstem—intracranial aneurysm	0.00473	0.0119	CbGeAlD
Vandetanib—EPHA5—cerebellum—intracranial aneurysm	0.0046	0.0116	CbGeAlD
Vandetanib—TYRO3—cerebellum—intracranial aneurysm	0.0046	0.0116	CbGeAlD
Vandetanib—RIPK2—midbrain—intracranial aneurysm	0.00456	0.0115	CbGeAlD
Vandetanib—BMPR1B—cerebellum—intracranial aneurysm	0.0045	0.0114	CbGeAlD
Vandetanib—MKNK1—medulla oblongata—intracranial aneurysm	0.00449	0.0113	CbGeAlD
Vandetanib—RET—medulla oblongata—intracranial aneurysm	0.00443	0.0112	CbGeAlD
Vandetanib—AXL—medulla oblongata—intracranial aneurysm	0.00441	0.0111	CbGeAlD
Vandetanib—ERBB3—midbrain—intracranial aneurysm	0.00437	0.011	CbGeAlD
Vandetanib—SLK—medulla oblongata—intracranial aneurysm	0.00425	0.0107	CbGeAlD
Vandetanib—FYN—medulla oblongata—intracranial aneurysm	0.00413	0.0104	CbGeAlD
Vandetanib—MKNK1—midbrain—intracranial aneurysm	0.0041	0.0103	CbGeAlD
Vandetanib—RET—midbrain—intracranial aneurysm	0.00405	0.0102	CbGeAlD
Vandetanib—TEK—medulla oblongata—intracranial aneurysm	0.00404	0.0102	CbGeAlD
Vandetanib—MAP4K5—medulla oblongata—intracranial aneurysm	0.00404	0.0102	CbGeAlD
Vandetanib—AXL—midbrain—intracranial aneurysm	0.00404	0.0102	CbGeAlD
Vandetanib—EPHA6—brain—intracranial aneurysm	0.00402	0.0101	CbGeAlD
Vandetanib—PLK4—brain—intracranial aneurysm	0.00397	0.01	CbGeAlD
Vandetanib—FLT3—cerebellum—intracranial aneurysm	0.00391	0.00986	CbGeAlD
Vandetanib—SLK—midbrain—intracranial aneurysm	0.00388	0.00979	CbGeAlD
Vandetanib—EPHB6—medulla oblongata—intracranial aneurysm	0.00386	0.00973	CbGeAlD
Vandetanib—STK35—cerebellum—intracranial aneurysm	0.00383	0.00966	CbGeAlD
Vandetanib—FYN—midbrain—intracranial aneurysm	0.00378	0.00952	CbGeAlD
Vandetanib—TYRO3—brain—intracranial aneurysm	0.00373	0.00941	CbGeAlD
Vandetanib—EPHA5—brain—intracranial aneurysm	0.00373	0.00941	CbGeAlD
Vandetanib—ABL2—cerebellum—intracranial aneurysm	0.00373	0.00941	CbGeAlD
Vandetanib—YES1—medulla oblongata—intracranial aneurysm	0.00373	0.0094	CbGeAlD
Vandetanib—LYN—brain—intracranial aneurysm	0.00371	0.00937	CbGeAlD
Vandetanib—MAP4K5—midbrain—intracranial aneurysm	0.00369	0.00931	CbGeAlD
Vandetanib—TEK—midbrain—intracranial aneurysm	0.00369	0.00931	CbGeAlD
Vandetanib—BMPR1B—brain—intracranial aneurysm	0.00366	0.00922	CbGeAlD
Vandetanib—MAP3K19—brain—intracranial aneurysm	0.00366	0.00922	CbGeAlD
Vandetanib—ABL1—brainstem—intracranial aneurysm	0.00365	0.00921	CbGeAlD
Vandetanib—EGFR—cerebellum—intracranial aneurysm	0.00364	0.00918	CbGeAlD
Vandetanib—RIPK2—cerebellum—intracranial aneurysm	0.00353	0.0089	CbGeAlD
Vandetanib—EPHB6—midbrain—intracranial aneurysm	0.00353	0.00889	CbGeAlD
Vandetanib—VEGFA—cerebellum—intracranial aneurysm	0.00352	0.00888	CbGeAlD
Vandetanib—IRAK4—cerebellum—intracranial aneurysm	0.00345	0.00869	CbGeAlD
Vandetanib—YES1—midbrain—intracranial aneurysm	0.00341	0.00859	CbGeAlD
Vandetanib—ERBB3—cerebellum—intracranial aneurysm	0.00338	0.00852	CbGeAlD
Vandetanib—MAP2K5—medulla oblongata—intracranial aneurysm	0.0033	0.00832	CbGeAlD
Vandetanib—KDR—medulla oblongata—intracranial aneurysm	0.0033	0.00832	CbGeAlD
Vandetanib—MKNK1—cerebellum—intracranial aneurysm	0.00317	0.008	CbGeAlD
Vandetanib—RET—cerebellum—intracranial aneurysm	0.00313	0.0079	CbGeAlD
Vandetanib—AXL—cerebellum—intracranial aneurysm	0.00312	0.00787	CbGeAlD
Vandetanib—STK35—brain—intracranial aneurysm	0.00311	0.00784	CbGeAlD
Vandetanib—ABL2—brain—intracranial aneurysm	0.00303	0.00764	CbGeAlD
Vandetanib—KDR—midbrain—intracranial aneurysm	0.00302	0.00761	CbGeAlD
Vandetanib—MAP2K5—midbrain—intracranial aneurysm	0.00302	0.00761	CbGeAlD
Vandetanib—SLK—cerebellum—intracranial aneurysm	0.003	0.00758	CbGeAlD
Vandetanib—EGFR—brain—intracranial aneurysm	0.00296	0.00746	CbGeAlD
Vandetanib—FYN—cerebellum—intracranial aneurysm	0.00292	0.00737	CbGeAlD
Vandetanib—FLT4—brain—intracranial aneurysm	0.00288	0.00727	CbGeAlD
Vandetanib—RIPK2—brain—intracranial aneurysm	0.00287	0.00723	CbGeAlD
Vandetanib—VEGFA—brain—intracranial aneurysm	0.00286	0.00721	CbGeAlD
Vandetanib—PDGFRB—medulla oblongata—intracranial aneurysm	0.00286	0.0072	CbGeAlD
Vandetanib—MAP4K5—cerebellum—intracranial aneurysm	0.00285	0.0072	CbGeAlD
Vandetanib—TEK—cerebellum—intracranial aneurysm	0.00285	0.0072	CbGeAlD
Vandetanib—FMO1—brain—intracranial aneurysm	0.00284	0.00717	CbGeAlD
Vandetanib—IRAK4—brain—intracranial aneurysm	0.0028	0.00706	CbGeAlD
Vandetanib—ERBB3—brain—intracranial aneurysm	0.00274	0.00692	CbGeAlD
Vandetanib—EPHB6—cerebellum—intracranial aneurysm	0.00273	0.00688	CbGeAlD
Vandetanib—YES1—cerebellum—intracranial aneurysm	0.00264	0.00665	CbGeAlD
Vandetanib—STK10—cerebellum—intracranial aneurysm	0.00261	0.00659	CbGeAlD
Vandetanib—PDGFRB—midbrain—intracranial aneurysm	0.00261	0.00658	CbGeAlD
Vandetanib—MKNK1—brain—intracranial aneurysm	0.00258	0.0065	CbGeAlD
Vandetanib—ABL1—medulla oblongata—intracranial aneurysm	0.00255	0.00642	CbGeAlD
Vandetanib—RET—brain—intracranial aneurysm	0.00255	0.00642	CbGeAlD
Vandetanib—FGR—brain—intracranial aneurysm	0.00255	0.00642	CbGeAlD
Vandetanib—SRC—cerebellum—intracranial aneurysm	0.00254	0.0064	CbGeAlD
Vandetanib—AXL—brain—intracranial aneurysm	0.00254	0.00639	CbGeAlD
Vandetanib—FMO3—brain—intracranial aneurysm	0.00246	0.0062	CbGeAlD
Vandetanib—SLK—brain—intracranial aneurysm	0.00244	0.00615	CbGeAlD
Vandetanib—FYN—brain—intracranial aneurysm	0.00237	0.00598	CbGeAlD
Vandetanib—KDR—cerebellum—intracranial aneurysm	0.00233	0.00588	CbGeAlD
Vandetanib—MAP2K5—cerebellum—intracranial aneurysm	0.00233	0.00588	CbGeAlD
Vandetanib—ABL1—midbrain—intracranial aneurysm	0.00233	0.00587	CbGeAlD
Vandetanib—TEK—brain—intracranial aneurysm	0.00232	0.00585	CbGeAlD
Vandetanib—MAP4K5—brain—intracranial aneurysm	0.00232	0.00585	CbGeAlD
Vandetanib—EPHB6—brain—intracranial aneurysm	0.00222	0.00559	CbGeAlD
Vandetanib—YES1—brain—intracranial aneurysm	0.00214	0.0054	CbGeAlD
Vandetanib—STK10—brain—intracranial aneurysm	0.00212	0.00535	CbGeAlD
Vandetanib—SRC—brain—intracranial aneurysm	0.00206	0.0052	CbGeAlD
Vandetanib—PDGFRB—cerebellum—intracranial aneurysm	0.00202	0.00509	CbGeAlD
Vandetanib—MAP2K5—brain—intracranial aneurysm	0.0019	0.00478	CbGeAlD
Vandetanib—KDR—brain—intracranial aneurysm	0.0019	0.00478	CbGeAlD
Vandetanib—ABL1—cerebellum—intracranial aneurysm	0.0018	0.00454	CbGeAlD
Vandetanib—PDGFRB—brain—intracranial aneurysm	0.00164	0.00414	CbGeAlD
Vandetanib—ABCG2—medulla oblongata—intracranial aneurysm	0.00161	0.00405	CbGeAlD
Vandetanib—ABCG2—midbrain—intracranial aneurysm	0.00147	0.0037	CbGeAlD
Vandetanib—ABL1—brain—intracranial aneurysm	0.00146	0.00369	CbGeAlD
Vandetanib—ABCC1—cerebellum—intracranial aneurysm	0.00137	0.00346	CbGeAlD
Vandetanib—ALB—brain—intracranial aneurysm	0.00135	0.0034	CbGeAlD
Vandetanib—ABCG2—cerebellum—intracranial aneurysm	0.00114	0.00286	CbGeAlD
Vandetanib—ABCC1—brain—intracranial aneurysm	0.00111	0.00281	CbGeAlD
Vandetanib—ABCG2—brain—intracranial aneurysm	0.000922	0.00232	CbGeAlD
Vandetanib—RIPK2—Immune System—NCF1—intracranial aneurysm	0.000418	0.000693	CbGpPWpGaD
Vandetanib—EGFR—Spinal Cord Injury—MMP9—intracranial aneurysm	0.000417	0.000692	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—TIMP1—intracranial aneurysm	0.000417	0.000691	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—CTSB—intracranial aneurysm	0.000416	0.00069	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—CTSB—intracranial aneurysm	0.000414	0.000687	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—CTSK—intracranial aneurysm	0.000412	0.000683	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CTSK—intracranial aneurysm	0.000411	0.000681	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—AGER—intracranial aneurysm	0.000411	0.000681	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—CTSB—intracranial aneurysm	0.00041	0.000679	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—CTSB—intracranial aneurysm	0.000408	0.000677	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000408	0.000676	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—NCF1—intracranial aneurysm	0.000406	0.000673	CbGpPWpGaD
Vandetanib—BLK—Immune System—CTSB—intracranial aneurysm	0.000404	0.00067	CbGpPWpGaD
Vandetanib—VEGFA—Axon guidance—MMP2—intracranial aneurysm	0.000404	0.00067	CbGpPWpGaD
Vandetanib—EGFR—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000404	0.000669	CbGpPWpGaD
Vandetanib—FGR—Immune System—CTSB—intracranial aneurysm	0.000403	0.000668	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000403	0.000667	CbGpPWpGaD
Vandetanib—BLK—Immune System—NCF1—intracranial aneurysm	0.000402	0.000667	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—NCF1—intracranial aneurysm	0.000402	0.000667	CbGpPWpGaD
Vandetanib—FGR—Immune System—NCF1—intracranial aneurysm	0.000401	0.000664	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—CTSB—intracranial aneurysm	0.0004	0.000663	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—MMP9—intracranial aneurysm	0.000398	0.00066	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—NCF1—intracranial aneurysm	0.000398	0.000659	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—CTSS—intracranial aneurysm	0.000397	0.000657	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CTSK—intracranial aneurysm	0.000396	0.000656	CbGpPWpGaD
Vandetanib—EPHB6—Developmental Biology—MMP9—intracranial aneurysm	0.000395	0.000654	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—CTSB—intracranial aneurysm	0.000394	0.000652	CbGpPWpGaD
Vandetanib—YES1—Immune System—CTSK—intracranial aneurysm	0.000393	0.000651	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—NCF1—intracranial aneurysm	0.000392	0.000649	CbGpPWpGaD
Vandetanib—ERBB3—Disease—CST3—intracranial aneurysm	0.000391	0.000649	CbGpPWpGaD
Vandetanib—YES1—Axon guidance—MMP2—intracranial aneurysm	0.00039	0.000647	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CTSS—intracranial aneurysm	0.000381	0.000631	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00038	0.00063	CbGpPWpGaD
Vandetanib—EPHA6—Developmental Biology—MMP9—intracranial aneurysm	0.000371	0.000615	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—CTSB—intracranial aneurysm	0.000371	0.000614	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—NCF1—intracranial aneurysm	0.000369	0.000611	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—CTSK—intracranial aneurysm	0.000365	0.000605	CbGpPWpGaD
Vandetanib—EGFR—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000362	0.0006	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—AGER—intracranial aneurysm	0.000361	0.000597	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—CTSB—intracranial aneurysm	0.000354	0.000587	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CTSK—intracranial aneurysm	0.000351	0.000581	CbGpPWpGaD
Vandetanib—LCK—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000349	0.000578	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—TIMP1—intracranial aneurysm	0.000347	0.000575	CbGpPWpGaD
Vandetanib—SRC—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000344	0.000571	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—CTSB—intracranial aneurysm	0.000341	0.000566	CbGpPWpGaD
Vandetanib—ERBB3—Disease—NCF1—intracranial aneurysm	0.00034	0.000564	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CTSB—intracranial aneurysm	0.00034	0.000564	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—NCF1—intracranial aneurysm	0.000338	0.000561	CbGpPWpGaD
Vandetanib—KDR—Axon guidance—MMP9—intracranial aneurysm	0.000338	0.00056	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ASAH1—intracranial aneurysm	0.000335	0.000555	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CTSB—intracranial aneurysm	0.000328	0.000543	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—NCF1—intracranial aneurysm	0.000326	0.00054	CbGpPWpGaD
Vandetanib—YES1—Immune System—CTSB—intracranial aneurysm	0.000325	0.000539	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CTSS—intracranial aneurysm	0.000325	0.000539	CbGpPWpGaD
Vandetanib—YES1—Immune System—NCF1—intracranial aneurysm	0.000324	0.000536	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—MMP2—intracranial aneurysm	0.000321	0.000532	CbGpPWpGaD
Vandetanib—LYN—Immune System—CTSS—intracranial aneurysm	0.000318	0.000528	CbGpPWpGaD
Vandetanib—FGR—Hemostasis—NOS3—intracranial aneurysm	0.000317	0.000526	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CTSS—intracranial aneurysm	0.000317	0.000525	CbGpPWpGaD
Vandetanib—FYN—Immune System—CTSS—intracranial aneurysm	0.000313	0.000519	CbGpPWpGaD
Vandetanib—SRC—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000309	0.000512	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—TIMP1—intracranial aneurysm	0.000307	0.000509	CbGpPWpGaD
Vandetanib—VEGFA—Axon guidance—MMP9—intracranial aneurysm	0.000304	0.000503	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—CTSB—intracranial aneurysm	0.000302	0.000501	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—AGER—intracranial aneurysm	0.0003	0.000497	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CTSK—intracranial aneurysm	0.000299	0.000496	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ASAH1—intracranial aneurysm	0.000294	0.000488	CbGpPWpGaD
Vandetanib—YES1—Axon guidance—MMP9—intracranial aneurysm	0.000293	0.000486	CbGpPWpGaD
Vandetanib—LYN—Immune System—CTSK—intracranial aneurysm	0.000293	0.000486	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CTSK—intracranial aneurysm	0.000292	0.000483	CbGpPWpGaD
Vandetanib—LYN—Axon guidance—MMP2—intracranial aneurysm	0.000291	0.000482	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CTSB—intracranial aneurysm	0.00029	0.000481	CbGpPWpGaD
Vandetanib—ABL1—Axon guidance—MMP2—intracranial aneurysm	0.00029	0.00048	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—NCF1—intracranial aneurysm	0.000289	0.000478	CbGpPWpGaD
Vandetanib—FYN—Immune System—CTSK—intracranial aneurysm	0.000288	0.000478	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—MMP2—intracranial aneurysm	0.000288	0.000478	CbGpPWpGaD
Vandetanib—FYN—Axon guidance—MMP2—intracranial aneurysm	0.000287	0.000475	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—MMP2—intracranial aneurysm	0.000279	0.000462	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—AGER—intracranial aneurysm	0.000275	0.000455	CbGpPWpGaD
Vandetanib—ALB—Metabolism—SLC25A16—intracranial aneurysm	0.000274	0.000455	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—AGER—intracranial aneurysm	0.000271	0.00045	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CTSS—intracranial aneurysm	0.000271	0.000449	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—NCF1—intracranial aneurysm	0.00027	0.000448	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—CCL2—intracranial aneurysm	0.00027	0.000448	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—AGER—intracranial aneurysm	0.000269	0.000445	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—AGER—intracranial aneurysm	0.000268	0.000443	CbGpPWpGaD
Vandetanib—VEGFA—Hemostasis—NOS3—intracranial aneurysm	0.000265	0.000439	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—AGER—intracranial aneurysm	0.000265	0.000439	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CST3—intracranial aneurysm	0.000262	0.000434	CbGpPWpGaD
Vandetanib—BLK—Immune System—AGER—intracranial aneurysm	0.000261	0.000433	CbGpPWpGaD
Vandetanib—LCK—Immune System—CTSS—intracranial aneurysm	0.000261	0.000432	CbGpPWpGaD
Vandetanib—FGR—Immune System—AGER—intracranial aneurysm	0.00026	0.000431	CbGpPWpGaD
Vandetanib—YES1—Hemostasis—NOS3—intracranial aneurysm	0.000256	0.000424	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000255	0.000423	CbGpPWpGaD
Vandetanib—FYN—Disease—CST3—intracranial aneurysm	0.000252	0.000418	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CTSK—intracranial aneurysm	0.000249	0.000413	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CTSB—intracranial aneurysm	0.000248	0.000411	CbGpPWpGaD
Vandetanib—EGFR—Axon guidance—MMP2—intracranial aneurysm	0.000248	0.00041	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—NCF1—intracranial aneurysm	0.000247	0.00041	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—CCL2—intracranial aneurysm	0.000247	0.000409	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—NCF1—intracranial aneurysm	0.000246	0.000408	CbGpPWpGaD
Vandetanib—LYN—Immune System—CTSB—intracranial aneurysm	0.000243	0.000402	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CTSB—intracranial aneurysm	0.000241	0.0004	CbGpPWpGaD
Vandetanib—LYN—Immune System—NCF1—intracranial aneurysm	0.000241	0.0004	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—MMP9—intracranial aneurysm	0.000241	0.0004	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—NCF1—intracranial aneurysm	0.000241	0.000399	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—NOS3—intracranial aneurysm	0.000241	0.000399	CbGpPWpGaD
Vandetanib—ABL1—Immune System—NCF1—intracranial aneurysm	0.00024	0.000398	CbGpPWpGaD
Vandetanib—LCK—Immune System—CTSK—intracranial aneurysm	0.00024	0.000398	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—AGER—intracranial aneurysm	0.000239	0.000396	CbGpPWpGaD
Vandetanib—FYN—Immune System—CTSB—intracranial aneurysm	0.000239	0.000396	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—NCF1—intracranial aneurysm	0.000238	0.000395	CbGpPWpGaD
Vandetanib—MKNK1—Disease—NOS3—intracranial aneurysm	0.000238	0.000395	CbGpPWpGaD
Vandetanib—FYN—Immune System—NCF1—intracranial aneurysm	0.000238	0.000394	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—EDNRA—intracranial aneurysm	0.000234	0.000387	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CST3—intracranial aneurysm	0.000231	0.000383	CbGpPWpGaD
Vandetanib—SRC—Immune System—CTSS—intracranial aneurysm	0.000231	0.000383	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—AGER—intracranial aneurysm	0.000229	0.000379	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—EDNRA—intracranial aneurysm	0.000228	0.000377	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—NCF1—intracranial aneurysm	0.000228	0.000377	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—CCL2—intracranial aneurysm	0.000226	0.000374	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—EDNRA—intracranial aneurysm	0.000225	0.000373	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—AGER—intracranial aneurysm	0.00022	0.000365	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—NOS3—intracranial aneurysm	0.00022	0.000365	CbGpPWpGaD
Vandetanib—FYN—Disease—NCF1—intracranial aneurysm	0.000219	0.000363	CbGpPWpGaD
Vandetanib—LYN—Axon guidance—MMP9—intracranial aneurysm	0.000219	0.000363	CbGpPWpGaD
Vandetanib—EGFR—Disease—CST3—intracranial aneurysm	0.000218	0.000361	CbGpPWpGaD
Vandetanib—ABL1—Axon guidance—MMP9—intracranial aneurysm	0.000218	0.000361	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—MMP9—intracranial aneurysm	0.000217	0.000359	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—NCF1—intracranial aneurysm	0.000217	0.000359	CbGpPWpGaD
Vandetanib—FYN—Axon guidance—MMP9—intracranial aneurysm	0.000215	0.000357	CbGpPWpGaD
Vandetanib—SRC—Immune System—CTSK—intracranial aneurysm	0.000213	0.000352	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000212	0.000352	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—MMP2—intracranial aneurysm	0.000211	0.00035	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—NOS3—intracranial aneurysm	0.00021	0.000349	CbGpPWpGaD
Vandetanib—LCK—Disease—CST3—intracranial aneurysm	0.00021	0.000348	CbGpPWpGaD
Vandetanib—YES1—Immune System—AGER—intracranial aneurysm	0.00021	0.000348	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—MMP9—intracranial aneurysm	0.000209	0.000347	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—NCF1—intracranial aneurysm	0.000209	0.000347	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—MMP2—intracranial aneurysm	0.000208	0.000344	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TIMP1—intracranial aneurysm	0.000207	0.000344	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—MMP2—intracranial aneurysm	0.000207	0.000343	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CTSB—intracranial aneurysm	0.000206	0.000342	CbGpPWpGaD
Vandetanib—EGFR—Immune System—NCF1—intracranial aneurysm	0.000205	0.00034	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—EDNRA—intracranial aneurysm	0.000205	0.000339	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—MMP2—intracranial aneurysm	0.000204	0.000339	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—NOS3—intracranial aneurysm	0.000201	0.000334	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NCF1—intracranial aneurysm	0.000201	0.000333	CbGpPWpGaD
Vandetanib—LCK—Immune System—CTSB—intracranial aneurysm	0.000199	0.000329	CbGpPWpGaD
Vandetanib—LCK—Immune System—NCF1—intracranial aneurysm	0.000198	0.000328	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000198	0.000327	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—AGER—intracranial aneurysm	0.000195	0.000323	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—MMP9—intracranial aneurysm	0.000193	0.00032	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—NOS3—intracranial aneurysm	0.000191	0.000316	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—NOS3—intracranial aneurysm	0.00019	0.000315	CbGpPWpGaD
Vandetanib—EGFR—Disease—NCF1—intracranial aneurysm	0.000189	0.000314	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—NOS3—intracranial aneurysm	0.000188	0.000311	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—CCL2—intracranial aneurysm	0.000187	0.00031	CbGpPWpGaD
Vandetanib—EGFR—Axon guidance—MMP9—intracranial aneurysm	0.000186	0.000308	CbGpPWpGaD
Vandetanib—SRC—Disease—CST3—intracranial aneurysm	0.000186	0.000308	CbGpPWpGaD
Vandetanib—LCK—Disease—NCF1—intracranial aneurysm	0.000183	0.000303	CbGpPWpGaD
Vandetanib—ALB—Metabolism—ASAH1—intracranial aneurysm	0.000182	0.000301	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—MMP2—intracranial aneurysm	0.000177	0.000293	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—MMP9—intracranial aneurysm	0.000177	0.000293	CbGpPWpGaD
Vandetanib—SRC—Immune System—CTSB—intracranial aneurysm	0.000176	0.000292	CbGpPWpGaD
Vandetanib—SRC—Immune System—NCF1—intracranial aneurysm	0.000175	0.00029	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—NOS3—intracranial aneurysm	0.000167	0.000276	CbGpPWpGaD
Vandetanib—SRC—Disease—NCF1—intracranial aneurysm	0.000162	0.000268	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—MMP9—intracranial aneurysm	0.000162	0.000268	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—AGER—intracranial aneurysm	0.00016	0.000265	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NCF1—intracranial aneurysm	0.000159	0.000264	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—MMP9—intracranial aneurysm	0.000159	0.000263	CbGpPWpGaD
Vandetanib—LYN—Immune System—AGER—intracranial aneurysm	0.000157	0.000259	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—NOS3—intracranial aneurysm	0.000156	0.000259	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—MMP9—intracranial aneurysm	0.000156	0.000259	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NCF1—intracranial aneurysm	0.000156	0.000259	CbGpPWpGaD
Vandetanib—ABL1—Immune System—AGER—intracranial aneurysm	0.000156	0.000258	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—MMP9—intracranial aneurysm	0.000155	0.000257	CbGpPWpGaD
Vandetanib—FYN—Immune System—AGER—intracranial aneurysm	0.000154	0.000255	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—MMP9—intracranial aneurysm	0.000154	0.000255	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NCF1—intracranial aneurysm	0.000154	0.000255	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—MMP2—intracranial aneurysm	0.000151	0.00025	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—EDNRA—intracranial aneurysm	0.00015	0.000249	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—NOS3—intracranial aneurysm	0.00015	0.000249	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000148	0.000245	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—EDNRA—intracranial aneurysm	0.000147	0.000244	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—EDNRA—intracranial aneurysm	0.000145	0.00024	CbGpPWpGaD
Vandetanib—ERBB3—Disease—NOS3—intracranial aneurysm	0.000141	0.000234	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—NOS3—intracranial aneurysm	0.000138	0.00023	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—MMP9—intracranial aneurysm	0.000134	0.000222	CbGpPWpGaD
Vandetanib—EGFR—Immune System—AGER—intracranial aneurysm	0.000133	0.000221	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—MMP9—intracranial aneurysm	0.000133	0.00022	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NCF1—intracranial aneurysm	0.000133	0.00022	CbGpPWpGaD
Vandetanib—LCK—Immune System—AGER—intracranial aneurysm	0.000128	0.000213	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NCF1—intracranial aneurysm	0.000128	0.000212	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—CCL2—intracranial aneurysm	0.000126	0.000209	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—EDNRA—intracranial aneurysm	0.000125	0.000208	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—EDNRA—intracranial aneurysm	0.000121	0.0002	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—CCL2—intracranial aneurysm	0.000115	0.000191	CbGpPWpGaD
Vandetanib—SRC—Immune System—AGER—intracranial aneurysm	0.000114	0.000188	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—MMP9—intracranial aneurysm	0.000113	0.000188	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NCF1—intracranial aneurysm	0.000113	0.000188	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—NOS3—intracranial aneurysm	0.000112	0.000186	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—CCL2—intracranial aneurysm	0.000112	0.000186	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CCL2—intracranial aneurysm	0.000111	0.000184	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—EDNRA—intracranial aneurysm	0.000107	0.000177	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—CCL2—intracranial aneurysm	0.000105	0.000173	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—NOS3—intracranial aneurysm	0.000103	0.00017	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CCL2—intracranial aneurysm	0.000101	0.000167	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—NOS3—intracranial aneurysm	9.99e-05	0.000166	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—NOS3—intracranial aneurysm	9.89e-05	0.000164	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	9.81e-05	0.000163	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CCL2—intracranial aneurysm	9.74e-05	0.000161	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—NOS3—intracranial aneurysm	9.44e-05	0.000156	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—NOS3—intracranial aneurysm	9.35e-05	0.000155	CbGpPWpGaD
Vandetanib—FYN—Disease—NOS3—intracranial aneurysm	9.1e-05	0.000151	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MMP9—intracranial aneurysm	9e-05	0.000149	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—NOS3—intracranial aneurysm	8.98e-05	0.000149	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—NOS3—intracranial aneurysm	8.68e-05	0.000144	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NOS3—intracranial aneurysm	8.34e-05	0.000138	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MMP9—intracranial aneurysm	8.23e-05	0.000136	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MMP9—intracranial aneurysm	8.02e-05	0.000133	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MMP9—intracranial aneurysm	7.93e-05	0.000131	CbGpPWpGaD
Vandetanib—EGFR—Disease—NOS3—intracranial aneurysm	7.86e-05	0.00013	CbGpPWpGaD
Vandetanib—LCK—Disease—NOS3—intracranial aneurysm	7.57e-05	0.000126	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCL2—intracranial aneurysm	7.41e-05	0.000123	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCL2—intracranial aneurysm	7.26e-05	0.00012	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP9—intracranial aneurysm	7.21e-05	0.000119	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCL2—intracranial aneurysm	7.15e-05	0.000118	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—NOS3—intracranial aneurysm	6.98e-05	0.000116	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP9—intracranial aneurysm	6.96e-05	0.000115	CbGpPWpGaD
Vandetanib—SRC—Disease—NOS3—intracranial aneurysm	6.7e-05	0.000111	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NOS3—intracranial aneurysm	6.61e-05	0.00011	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NOS3—intracranial aneurysm	6.47e-05	0.000107	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NOS3—intracranial aneurysm	6.37e-05	0.000106	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCL2—intracranial aneurysm	6.17e-05	0.000102	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—NOS3—intracranial aneurysm	6.14e-05	0.000102	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCL2—intracranial aneurysm	5.95e-05	9.86e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NOS3—intracranial aneurysm	5.5e-05	9.12e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NOS3—intracranial aneurysm	5.3e-05	8.79e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP9—intracranial aneurysm	5.3e-05	8.79e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL2—intracranial aneurysm	5.27e-05	8.73e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP9—intracranial aneurysm	5.19e-05	8.6e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP9—intracranial aneurysm	5.11e-05	8.47e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NOS3—intracranial aneurysm	4.7e-05	7.78e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP9—intracranial aneurysm	4.42e-05	7.32e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP9—intracranial aneurysm	4.26e-05	7.05e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—NOS3—intracranial aneurysm	3.79e-05	6.28e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP9—intracranial aneurysm	3.77e-05	6.24e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NOS3—intracranial aneurysm	2.05e-05	3.39e-05	CbGpPWpGaD
